Drug Levels and Effects
Summary of Use during Lactation
Information in this record refers to the use of d-xylose C 14 as a diagnostic agent. Breastfeeding does not need to be suspended after administration of d-xylose C 14.
Drug Levels
Carbon 14 is a low-energy beta emitter with a physical half-life of about 5730 years.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
d-Xylose C14
Drug Class
Breast Feeding
Lactation
Radiopharmaceuticals
Carbon Radioisotopes
Diagnostic Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
Publication Details
Publication History
Last Revision: August 17, 2020.
Copyright
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Publisher
National Institute of Child Health and Human Development, Bethesda (MD)
NLM Citation
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-. d-Xylose C14. [Updated 2020 Aug 17].